An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes

被引:93
作者
Fujimoto, M
Masuzaki, H
Tanaka, T
Yasue, S
Tomita, T
Okazawa, K
Fujikura, J
Chusho, H
Ebihara, K
Hayashi, T
Hosoda, K
Nakao, K
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Div Endocrinol & Metab,Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan
关键词
telmisartan; angiotensin II AT(1); receptor antagonist; peroxisome proliferator-activated receptor gamma; adipocyte; glucose uptake; GLUT4;
D O I
10.1016/j.febslet.2004.09.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evidence has accumulated that some of the angiotensin II AT(1) receptor antagonists have insulin-sensitizing property. We thus examined the effect of telmisartan on insulin action using 3T3-L1 adipocytes. With standard differentiation inducers, a higher dose of telmisartan effectively facilitated differentiation of 3T3-L1 preadipocytes. Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose-dependent increase in mRNA levels for PPARgamma target genes such as aP2 and adiponectin. By contrast, telmisartan attenuated 11beta-hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes. Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2-deoxy glucose uptake both in basal and insulin-stimulated state of adipocytes, which may contribute, at least partly, to its insulin-sensitizing ability. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:492 / 497
页数:6
相关论文
共 41 条
[1]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[2]   Peroxisome proliferator-activated receptor-γ represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect [J].
Armoni, M ;
Kritz, N ;
Harel, C ;
Bar-Yoseph, F ;
Chen, H ;
Quon, MJ ;
Karnieli, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30614-30623
[3]   Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity [J].
Benson, SC ;
Pershadsingh, HA ;
Ho, CI ;
Chittiboyina, A ;
Desai, P ;
Pravenec, M ;
Qi, NN ;
Wang, JM ;
Avery, MA ;
Kurtz, TW .
HYPERTENSION, 2004, 43 (05) :993-1002
[4]   Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity [J].
Berger, J ;
Tanen, M ;
Elbrecht, A ;
Hermanowski-Vosatka, A ;
Moller, DE ;
Wright, SD ;
Thieringer, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12629-12635
[5]   Toxicological consequences of altered peroxisome proliferator-activated receptor γ (PPARγ) expression in the liver:: insights from models of obesity and type 2 diabetes [J].
Boelsterli, UA ;
Bedoucha, M .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (01) :1-10
[6]  
CRANDALL DL, 1994, J LIPID RES, V35, P1378
[7]   The adipose-tissue renin-angiotensin-aldosterone system:: role in the metabolic syndrome? [J].
Engeli, S ;
Schling, P ;
Gorzelniak, K ;
Boschmann, M ;
Janke, E ;
Ailhaud, G ;
Teboul, M ;
Massiéra, F ;
Sharma, AA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (06) :807-825
[8]   Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels - A potential role for serine phosphorylation in insulin/angiotensin II crosstalk [J].
Folli, F ;
Kahn, CR ;
Hansen, H ;
Bouchie, JL ;
Feener, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2158-2169
[9]  
FROST SC, 1985, J BIOL CHEM, V260, P2646
[10]   Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat [J].
Hallakou, S ;
Doare, L ;
Foufelle, F ;
Kergoat, M ;
GuerreMillo, M ;
Berthault, MF ;
Dugail, I ;
Morin, J ;
Auwerx, J ;
Ferre, P .
DIABETES, 1997, 46 (09) :1393-1399